Prozac Maker Eli Lilly Just Bought a Psychedelics Company for $2.8 Billion — Here’s What It Could Mean for Mental Health Entrepreneur Magazine 14:48 Fri, 17 Jul
Eli Lilly Changed Depression Care With Prozac. Now It's Betting on Psychedelics with AtaiBeckley Acquisition IBTimes (US) 19:31 Thu, 16 Jul
RFK Jr. Targets Antidepressants Like Zoloft and Prozac — Pushes ‘More Holistic’ Mental Health Fixes Like Exercise, Diet and Family Support Barchart 22:25 Mon, 13 Jul
Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool 3d Amycretin Novo Nordisk Pharma All sources
Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Manufacturing Chemist 3d Obesity FDA Pharma All sources
With a little help from pharma friends: Psychedelics for psychiatric therapy The Economic Times 3d Pharma Biotechnology
Curious about Regeneron (REGN) Q2 Performance? Explore Wall Street Estimates for Key Metrics Zacks 10h Wall Street Regeneron Stock Market (US)
AstraZeneca sales boosted by soaring demand for cancer treatments The Independent 14h AstraZeneca FTSE 100 Rare Diseases Article paywall
Biotech is ‘leading innovative science, not universities’ Times Higher Education 1d Nobel Prizes Biotech Biotechnology Article paywall
